Acute myeloid leukemia: a comprehensive review and 2016 update
I De Kouchkovsky, M Abdul-Hay - Blood cancer journal, 2016 - nature.com
Acute myeloid leukemia (AML) is the most common acute leukemia in adults, with an
incidence of over 20 000 cases per year in the United States alone. Large chromosomal …
incidence of over 20 000 cases per year in the United States alone. Large chromosomal …
Chimeric antigen receptor T cells in acute myeloid leukemia
K Cummins, S Gill - Hematology/Oncology Clinics, 2023 - hemonc.theclinics.com
Background Approximately 20,000 Americans are diagnosed with AML each year at a
median age of diagnosis of 69, and the 5-year survival is approximately 31.7%(https://seer …
median age of diagnosis of 69, and the 5-year survival is approximately 31.7%(https://seer …
Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next …
In patients with acute myeloid leukemia (AML) consolidation treatment options are between
allogeneic hematopoietic stem cell transplantation (HCT) and chemotherapy, based on …
allogeneic hematopoietic stem cell transplantation (HCT) and chemotherapy, based on …
Hematopoietic stem cell transplantation for acute myeloid leukemia: an overview of systematic reviews
P He, J Liang, W Zhang, S Lin, H Wu… - … Journal of Clinical …, 2022 - Wiley Online Library
Background. Hematopoietic stem cell transplantation (HSCT) has become the main
treatment for acute myeloid leukemia (AML) and has been studied in many systematic …
treatment for acute myeloid leukemia (AML) and has been studied in many systematic …
[HTML][HTML] Evaluation of eltrombopag in thrombocytopenia post Hematopoietic cell transplantation: Rertrospective observational trial
H Samarkandi, M Al Nahedh, A Alfattani… - … /Oncology and Stem Cell …, 2020 - Elsevier
Background Thrombocytopenia remains a life-threatening late complication of HCT with an
incidence of 5–20%. Currently, there is no approved drug for the treatment of persistent …
incidence of 5–20%. Currently, there is no approved drug for the treatment of persistent …
[HTML][HTML] Long-term outcomes of patients with acute myelogenous leukemia treated with myeloablative fractionated total body irradiation TBI-based conditioning with a …
Cyclophosphamide (Cy)/etoposide combined with fractionated total body irradiation (FTBI)
or iv busulfan (Bu) has been the main conditioning regimens for allogeneic hematopoietic …
or iv busulfan (Bu) has been the main conditioning regimens for allogeneic hematopoietic …
Adolescents and young adults (AYA) with acute myeloid leukemia (AML): real-world long-term results and age-specific outcomes
C Lalayanni, C Demosthenous, M Iskas… - Leukemia & …, 2022 - Taylor & Francis
Opposing acute lymphoblastic leukemia, sparse data about AYAs with acute myeloid
leukemia (AML) is available. Overall, 125 AYAs (age 10–35 years) treated during the last …
leukemia (AML) is available. Overall, 125 AYAs (age 10–35 years) treated during the last …
[HTML][HTML] Acute myeloid leukemia: negative prognostic impact of early blast persistence can be in part overcome by a later remission prior to post-induction therapy
J Ihlow, S Gross, L Busack, A Flörcken, J Jesse… - …, 2022 - ncbi.nlm.nih.gov
In acute myeloid leukemia, there is an ongoing debate on the prognostic value of the early
bone marrow assessment in patients receiving intensive therapy. In this retrospective study …
bone marrow assessment in patients receiving intensive therapy. In this retrospective study …
The diagnostic and prognostic value of interleukin-10 in cerebrospinal fluid for central nervous system lymphoma: a meta-analysis
L Wang, L Luo, Z Gao, SF Liu, CJ Liu, DX Ma… - Leukemia & …, 2017 - Taylor & Francis
Central nervous system lymphoma (CNSL) presents diagnostic and prognostic challenges.
The aim of this meta-analysis was to evaluate the diagnostic and prognostic value of …
The aim of this meta-analysis was to evaluate the diagnostic and prognostic value of …
[HTML][HTML] Impact of marital status during diagnosis on cancer-caused specific survival in acute myeloid leukemia patients: a case-control and population-based study
Z Zheng, Y Zhu, X Li, W Hu, J Jiang - Oncotarget, 2017 - ncbi.nlm.nih.gov
Objective This study investigated the impact of marital status on cancer-caused specific
mortality among acute myeloid leukemia (AML) patients in the United States. Methods We …
mortality among acute myeloid leukemia (AML) patients in the United States. Methods We …